Registration

SPLITOAK STRATEGIES LLC for ACCELERON PHARMA, INC

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Rare disease patient access to needed therapies (HR 3), Value of Medicare Parts B and D

LobbyistCovered position, as disclosed
AMY JENSEN New Special Assistant to the President for Legislative Affairs; Assistant to the Speaker Of the House for Policy; Legislative Assistant; Policy Analyst

Bills named: H.R. 3 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.